Max Seibold
Concepts (386)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Asthma | 44 | 2023 | 2150 | 4.700 |
Why?
| Respiratory Mucosa | 13 | 2020 | 258 | 3.960 |
Why?
| Transcriptome | 10 | 2022 | 742 | 2.960 |
Why?
| Interleukin-13 | 10 | 2023 | 132 | 2.480 |
Why?
| Gene Expression Profiling | 16 | 2020 | 1550 | 2.180 |
Why?
| Nasal Mucosa | 7 | 2023 | 95 | 2.020 |
Why?
| Epithelial Cells | 12 | 2023 | 961 | 1.850 |
Why?
| Mucin 5AC | 5 | 2022 | 48 | 1.530 |
Why?
| Hypersensitivity | 4 | 2022 | 272 | 1.360 |
Why?
| Lung | 13 | 2023 | 3683 | 1.120 |
Why?
| Mucin-5B | 5 | 2020 | 185 | 1.060 |
Why?
| Polymorphism, Single Nucleotide | 17 | 2022 | 2004 | 1.050 |
Why?
| Genetic Predisposition to Disease | 14 | 2019 | 2201 | 1.020 |
Why?
| Th2 Cells | 6 | 2023 | 162 | 0.990 |
Why?
| Epithelium | 3 | 2023 | 297 | 0.910 |
Why?
| Single-Cell Analysis | 4 | 2021 | 181 | 0.890 |
Why?
| Hexosaminidases | 2 | 2016 | 17 | 0.860 |
Why?
| Interferons | 2 | 2020 | 152 | 0.850 |
Why?
| Particulate Matter | 2 | 2021 | 183 | 0.820 |
Why?
| Idiopathic Pulmonary Fibrosis | 5 | 2020 | 511 | 0.790 |
Why?
| Sequence Analysis, RNA | 8 | 2021 | 390 | 0.780 |
Why?
| Peptidyl-Dipeptidase A | 2 | 2021 | 53 | 0.780 |
Why?
| Enterovirus Infections | 2 | 2023 | 160 | 0.730 |
Why?
| Trachea | 2 | 2020 | 233 | 0.720 |
Why?
| High-Throughput Nucleotide Sequencing | 3 | 2018 | 446 | 0.720 |
Why?
| Serine Endopeptidases | 1 | 2020 | 102 | 0.710 |
Why?
| Gene Expression Regulation | 9 | 2023 | 2365 | 0.680 |
Why?
| Alveolar Epithelial Cells | 2 | 2018 | 100 | 0.670 |
Why?
| Respiratory Tract Infections | 3 | 2020 | 323 | 0.670 |
Why?
| Quantitative Trait Loci | 3 | 2020 | 322 | 0.670 |
Why?
| Pneumonia, Viral | 2 | 2020 | 344 | 0.630 |
Why?
| Coronavirus Infections | 2 | 2020 | 336 | 0.630 |
Why?
| Interleukin-1 Receptor-Like 1 Protein | 3 | 2019 | 23 | 0.630 |
Why?
| Betacoronavirus | 2 | 2020 | 254 | 0.620 |
Why?
| STAT6 Transcription Factor | 1 | 2018 | 23 | 0.620 |
Why?
| Genome, Human | 2 | 2018 | 372 | 0.620 |
Why?
| Host-Pathogen Interactions | 2 | 2020 | 296 | 0.610 |
Why?
| Bronchodilator Agents | 5 | 2023 | 251 | 0.610 |
Why?
| Smoking | 2 | 2020 | 1465 | 0.610 |
Why?
| Dermatitis, Atopic | 5 | 2019 | 337 | 0.610 |
Why?
| Proto-Oncogene Proteins c-ets | 1 | 2018 | 51 | 0.610 |
Why?
| Cadherins | 1 | 2019 | 175 | 0.600 |
Why?
| Humans | 74 | 2023 | 115859 | 0.600 |
Why?
| Gene Editing | 1 | 2018 | 62 | 0.580 |
Why?
| Pulmonary Disease, Chronic Obstructive | 3 | 2017 | 1115 | 0.580 |
Why?
| CRISPR-Cas Systems | 1 | 2018 | 82 | 0.570 |
Why?
| RNA Virus Infections | 1 | 2017 | 11 | 0.570 |
Why?
| RNA Viruses | 1 | 2017 | 28 | 0.560 |
Why?
| Gene Deletion | 1 | 2018 | 356 | 0.540 |
Why?
| Amides | 1 | 2016 | 89 | 0.530 |
Why?
| Lectins | 1 | 2016 | 47 | 0.530 |
Why?
| Adipokines | 1 | 2016 | 43 | 0.520 |
Why?
| Steroids | 1 | 2016 | 147 | 0.500 |
Why?
| Inflammation | 7 | 2023 | 2502 | 0.490 |
Why?
| Genome-Wide Association Study | 8 | 2023 | 1277 | 0.490 |
Why?
| Child | 25 | 2023 | 18537 | 0.470 |
Why?
| Pulmonary Fibrosis | 2 | 2023 | 331 | 0.470 |
Why?
| Forced Expiratory Volume | 5 | 2020 | 521 | 0.460 |
Why?
| Membrane Proteins | 2 | 2020 | 1033 | 0.460 |
Why?
| Case-Control Studies | 12 | 2020 | 3054 | 0.460 |
Why?
| Pyridines | 1 | 2016 | 425 | 0.430 |
Why?
| Chitinases | 2 | 2009 | 9 | 0.420 |
Why?
| Air Pollution | 3 | 2020 | 172 | 0.420 |
Why?
| Adrenal Cortex Hormones | 5 | 2021 | 510 | 0.410 |
Why?
| Stem Cells | 1 | 2016 | 546 | 0.410 |
Why?
| Haplotypes | 3 | 2011 | 475 | 0.400 |
Why?
| Gene Expression | 7 | 2023 | 1442 | 0.390 |
Why?
| Bronchi | 5 | 2020 | 250 | 0.390 |
Why?
| Metaplasia | 2 | 2022 | 54 | 0.390 |
Why?
| Animals | 22 | 2023 | 32158 | 0.380 |
Why?
| Picornaviridae Infections | 2 | 2023 | 29 | 0.380 |
Why?
| Lung Diseases | 1 | 2018 | 710 | 0.380 |
Why?
| Chromosomes, Human, Pair 11 | 1 | 2011 | 66 | 0.380 |
Why?
| Mucus | 2 | 2022 | 55 | 0.380 |
Why?
| Cells, Cultured | 7 | 2020 | 3914 | 0.360 |
Why?
| Mexican Americans | 3 | 2022 | 101 | 0.360 |
Why?
| Mice | 16 | 2023 | 15085 | 0.360 |
Why?
| Allergens | 4 | 2021 | 427 | 0.350 |
Why?
| Male | 37 | 2021 | 56103 | 0.330 |
Why?
| Cell Differentiation | 6 | 2018 | 1709 | 0.330 |
Why?
| Gene-Environment Interaction | 3 | 2020 | 185 | 0.320 |
Why?
| Genotype | 8 | 2019 | 1830 | 0.320 |
Why?
| Female | 37 | 2021 | 60070 | 0.320 |
Why?
| Large-Conductance Calcium-Activated Potassium Channel beta Subunits | 1 | 2008 | 9 | 0.320 |
Why?
| NIH 3T3 Cells | 2 | 2020 | 138 | 0.310 |
Why?
| Genomics | 3 | 2018 | 653 | 0.300 |
Why?
| Linkage Disequilibrium | 6 | 2020 | 268 | 0.300 |
Why?
| Cystic Fibrosis Transmembrane Conductance Regulator | 2 | 2022 | 288 | 0.300 |
Why?
| Cellular Reprogramming | 2 | 2020 | 84 | 0.300 |
Why?
| Sputum | 5 | 2023 | 291 | 0.300 |
Why?
| DNA Methylation | 3 | 2023 | 502 | 0.290 |
Why?
| Minority Groups | 3 | 2022 | 232 | 0.280 |
Why?
| Interleukin-33 | 2 | 2016 | 40 | 0.270 |
Why?
| Genetic Variation | 4 | 2020 | 893 | 0.270 |
Why?
| Adolescent | 20 | 2022 | 17935 | 0.270 |
Why?
| Polymorphism, Genetic | 3 | 2016 | 633 | 0.270 |
Why?
| Cilia | 2 | 2020 | 163 | 0.260 |
Why?
| Adult | 23 | 2022 | 30814 | 0.260 |
Why?
| Lung Diseases, Interstitial | 1 | 2011 | 520 | 0.260 |
Why?
| Immunity, Innate | 2 | 2021 | 735 | 0.250 |
Why?
| Cell Culture Techniques | 2 | 2018 | 345 | 0.240 |
Why?
| Transcription Factors | 4 | 2023 | 1535 | 0.240 |
Why?
| Skin | 2 | 2019 | 668 | 0.240 |
Why?
| Genetic Association Studies | 2 | 2016 | 352 | 0.230 |
Why?
| Middle Aged | 15 | 2021 | 27078 | 0.230 |
Why?
| Albuterol | 3 | 2023 | 106 | 0.230 |
Why?
| Pandemics | 3 | 2021 | 1337 | 0.230 |
Why?
| Environmental Exposure | 3 | 2017 | 380 | 0.230 |
Why?
| Puerto Rico | 5 | 2020 | 53 | 0.230 |
Why?
| Helminthiasis | 1 | 2023 | 14 | 0.220 |
Why?
| Rhinovirus | 2 | 2023 | 40 | 0.220 |
Why?
| Chemokine CCL5 | 1 | 2023 | 48 | 0.220 |
Why?
| Epigenesis, Genetic | 3 | 2023 | 533 | 0.210 |
Why?
| Nasal Polyps | 1 | 2023 | 49 | 0.210 |
Why?
| Pulmonary Surfactants | 1 | 2023 | 101 | 0.210 |
Why?
| Salmeterol Xinafoate | 1 | 2021 | 42 | 0.200 |
Why?
| Surgical Tape | 2 | 2019 | 3 | 0.200 |
Why?
| Cystic Fibrosis | 2 | 2022 | 960 | 0.200 |
Why?
| Fluticasone | 1 | 2021 | 87 | 0.200 |
Why?
| Strongylida Infections | 1 | 2021 | 6 | 0.200 |
Why?
| Biomarkers | 4 | 2022 | 3474 | 0.200 |
Why?
| Macrophages, Alveolar | 2 | 2019 | 357 | 0.190 |
Why?
| Gene Regulatory Networks | 2 | 2020 | 234 | 0.190 |
Why?
| Rhinitis | 1 | 2023 | 128 | 0.190 |
Why?
| Pharmacogenomic Testing | 1 | 2021 | 54 | 0.190 |
Why?
| Down-Regulation | 2 | 2021 | 605 | 0.190 |
Why?
| Chromosomes, Human, Pair 5 | 1 | 2020 | 26 | 0.190 |
Why?
| Interleukin-4 | 2 | 2020 | 212 | 0.180 |
Why?
| Sinusitis | 1 | 2023 | 175 | 0.180 |
Why?
| Virus Internalization | 1 | 2020 | 41 | 0.180 |
Why?
| Epidermis | 2 | 2019 | 150 | 0.180 |
Why?
| Gene Frequency | 3 | 2011 | 506 | 0.180 |
Why?
| Signal Transduction | 5 | 2020 | 4527 | 0.180 |
Why?
| fas Receptor | 1 | 2020 | 93 | 0.180 |
Why?
| Chromosomes, Human, Pair 1 | 1 | 2020 | 69 | 0.180 |
Why?
| Stem Cell Factor | 1 | 2020 | 14 | 0.180 |
Why?
| Keratinocytes | 2 | 2018 | 218 | 0.180 |
Why?
| Gene Knockout Techniques | 1 | 2020 | 99 | 0.170 |
Why?
| Neutrophils | 3 | 2023 | 1171 | 0.170 |
Why?
| Clinical Decision-Making | 1 | 2022 | 273 | 0.170 |
Why?
| Endoplasmic Reticulum Stress | 1 | 2020 | 92 | 0.170 |
Why?
| Coronavirus | 1 | 2020 | 40 | 0.170 |
Why?
| Air Pollutants | 2 | 2020 | 247 | 0.170 |
Why?
| Lymphocytes | 1 | 2021 | 342 | 0.170 |
Why?
| Chromosomal Proteins, Non-Histone | 1 | 2020 | 101 | 0.170 |
Why?
| Smokers | 1 | 2020 | 147 | 0.170 |
Why?
| Biological Transport | 1 | 2020 | 375 | 0.170 |
Why?
| Cadherin Related Proteins | 1 | 2019 | 12 | 0.170 |
Why?
| Interleukin-1 Receptor-Associated Kinases | 1 | 2019 | 21 | 0.170 |
Why?
| Young Adult | 12 | 2021 | 10508 | 0.170 |
Why?
| Immunologic Memory | 1 | 2021 | 312 | 0.170 |
Why?
| CD11c Antigen | 1 | 2019 | 38 | 0.160 |
Why?
| Dendritic Cells | 2 | 2019 | 438 | 0.160 |
Why?
| Clone Cells | 2 | 2016 | 247 | 0.160 |
Why?
| Eczema | 1 | 2019 | 83 | 0.160 |
Why?
| Chromosomes, Human, Pair 18 | 1 | 2018 | 12 | 0.160 |
Why?
| Cytokines | 4 | 2023 | 1858 | 0.160 |
Why?
| Cell Line | 5 | 2020 | 2657 | 0.160 |
Why?
| Smad2 Protein | 1 | 2018 | 34 | 0.160 |
Why?
| Pharmacogenetics | 2 | 2010 | 154 | 0.160 |
Why?
| Receptors, Odorant | 1 | 2018 | 35 | 0.160 |
Why?
| Enterovirus | 1 | 2019 | 72 | 0.160 |
Why?
| Pharmacogenomic Variants | 1 | 2018 | 34 | 0.160 |
Why?
| Lung Neoplasms | 2 | 2023 | 2206 | 0.160 |
Why?
| Acetyltransferases | 1 | 2018 | 20 | 0.150 |
Why?
| Airway Remodeling | 1 | 2018 | 60 | 0.150 |
Why?
| Eosinophilia | 1 | 2020 | 187 | 0.150 |
Why?
| Molecular Sequence Annotation | 1 | 2018 | 83 | 0.150 |
Why?
| Sequence Analysis, DNA | 2 | 2018 | 737 | 0.150 |
Why?
| Glycoproteins | 1 | 2019 | 311 | 0.140 |
Why?
| Epigenomics | 2 | 2023 | 106 | 0.140 |
Why?
| Phosphoproteins | 1 | 2019 | 302 | 0.140 |
Why?
| Cell-Matrix Junctions | 1 | 2016 | 2 | 0.140 |
Why?
| Cockroaches | 1 | 2016 | 22 | 0.140 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2019 | 389 | 0.140 |
Why?
| Gene Expression Regulation, Viral | 1 | 2017 | 80 | 0.140 |
Why?
| Culture Media | 1 | 2016 | 156 | 0.140 |
Why?
| Nose | 1 | 2016 | 56 | 0.140 |
Why?
| Plasminogen Activator Inhibitor 1 | 1 | 2016 | 82 | 0.130 |
Why?
| Bronchiolitis, Viral | 1 | 2015 | 10 | 0.130 |
Why?
| Data Interpretation, Statistical | 1 | 2018 | 325 | 0.130 |
Why?
| Fibroblasts | 2 | 2020 | 838 | 0.130 |
Why?
| Risk Factors | 5 | 2022 | 8715 | 0.130 |
Why?
| In Vitro Techniques | 1 | 2018 | 1044 | 0.130 |
Why?
| Receptors, Adrenergic, beta-2 | 1 | 2015 | 43 | 0.130 |
Why?
| Respiratory Function Tests | 3 | 2016 | 539 | 0.130 |
Why?
| Urban Population | 2 | 2016 | 405 | 0.130 |
Why?
| Influenza, Human | 1 | 2021 | 549 | 0.130 |
Why?
| CD4-Positive T-Lymphocytes | 1 | 2021 | 967 | 0.130 |
Why?
| Genomic Imprinting | 1 | 2015 | 32 | 0.130 |
Why?
| Genetic Testing | 1 | 2018 | 383 | 0.130 |
Why?
| Indians, North American | 1 | 2020 | 592 | 0.120 |
Why?
| Lipid Metabolism | 1 | 2018 | 449 | 0.120 |
Why?
| Cell Communication | 1 | 2016 | 280 | 0.120 |
Why?
| Alternative Splicing | 1 | 2016 | 187 | 0.120 |
Why?
| Homeodomain Proteins | 1 | 2018 | 465 | 0.120 |
Why?
| Administration, Inhalation | 4 | 2021 | 646 | 0.120 |
Why?
| Food Hypersensitivity | 1 | 2019 | 254 | 0.120 |
Why?
| Eosinophils | 3 | 2023 | 283 | 0.120 |
Why?
| Up-Regulation | 2 | 2018 | 824 | 0.120 |
Why?
| Pulmonary Emphysema | 1 | 2017 | 318 | 0.120 |
Why?
| Computational Biology | 1 | 2018 | 540 | 0.110 |
Why?
| CD8-Positive T-Lymphocytes | 1 | 2019 | 688 | 0.110 |
Why?
| Software | 1 | 2018 | 542 | 0.110 |
Why?
| Prospective Studies | 2 | 2022 | 6276 | 0.110 |
Why?
| Cholesterol Side-Chain Cleavage Enzyme | 1 | 2013 | 14 | 0.110 |
Why?
| Repetitive Sequences, Nucleic Acid | 1 | 2014 | 104 | 0.110 |
Why?
| Matrix Metalloproteinase 7 | 1 | 2013 | 24 | 0.110 |
Why?
| Exons | 1 | 2014 | 303 | 0.110 |
Why?
| Receptors, Purinergic P2X7 | 1 | 2012 | 11 | 0.110 |
Why?
| Bronchoalveolar Lavage Fluid | 2 | 2021 | 609 | 0.110 |
Why?
| Extracellular Matrix | 1 | 2016 | 439 | 0.110 |
Why?
| Islets of Langerhans | 1 | 2019 | 729 | 0.110 |
Why?
| Cysts | 1 | 2013 | 94 | 0.100 |
Why?
| Lipids | 3 | 2023 | 589 | 0.100 |
Why?
| RNA, Small Interfering | 3 | 2019 | 545 | 0.100 |
Why?
| Dinoprostone | 2 | 2023 | 188 | 0.100 |
Why?
| Phenotype | 3 | 2014 | 2859 | 0.100 |
Why?
| Recombinant Proteins | 2 | 2019 | 1244 | 0.100 |
Why?
| Precision Medicine | 1 | 2015 | 356 | 0.100 |
Why?
| Microscopy, Fluorescence | 1 | 2013 | 402 | 0.100 |
Why?
| Chromosome Mapping | 3 | 2020 | 505 | 0.100 |
Why?
| T-Lymphocytes | 1 | 2019 | 1758 | 0.090 |
Why?
| Mice, Inbred C57BL | 4 | 2021 | 4779 | 0.090 |
Why?
| Beclomethasone | 1 | 2010 | 25 | 0.090 |
Why?
| Anaphylaxis | 1 | 2013 | 148 | 0.090 |
Why?
| Dual Specificity Phosphatase 1 | 1 | 2010 | 29 | 0.090 |
Why?
| Promoter Regions, Genetic | 2 | 2013 | 1130 | 0.090 |
Why?
| Genetic Linkage | 1 | 2011 | 314 | 0.090 |
Why?
| United States | 8 | 2021 | 12319 | 0.090 |
Why?
| Intestines | 1 | 2013 | 325 | 0.090 |
Why?
| Alleles | 3 | 2019 | 817 | 0.090 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2011 | 275 | 0.090 |
Why?
| Antigens, Bacterial | 1 | 2010 | 112 | 0.090 |
Why?
| Mice, Knockout | 3 | 2021 | 2608 | 0.090 |
Why?
| Peanut Hypersensitivity | 1 | 2013 | 201 | 0.090 |
Why?
| Vital Capacity | 1 | 2010 | 279 | 0.080 |
Why?
| Disaccharides | 1 | 2009 | 16 | 0.080 |
Why?
| Genetic Loci | 1 | 2011 | 280 | 0.080 |
Why?
| Disease Models, Animal | 4 | 2021 | 3587 | 0.080 |
Why?
| Environmental Pollutants | 1 | 2011 | 111 | 0.080 |
Why?
| Insecta | 1 | 2009 | 65 | 0.080 |
Why?
| RNA | 2 | 2013 | 820 | 0.080 |
Why?
| Mexico | 1 | 2009 | 163 | 0.080 |
Why?
| Disease Susceptibility | 1 | 2010 | 321 | 0.080 |
Why?
| San Francisco | 1 | 2008 | 56 | 0.080 |
Why?
| Substrate Specificity | 1 | 2009 | 357 | 0.080 |
Why?
| Isoenzymes | 1 | 2009 | 287 | 0.080 |
Why?
| Catalysis | 1 | 2009 | 299 | 0.080 |
Why?
| Primary Cell Culture | 2 | 2019 | 148 | 0.080 |
Why?
| Molecular Structure | 1 | 2009 | 447 | 0.080 |
Why?
| Hydrogen-Ion Concentration | 1 | 2009 | 515 | 0.080 |
Why?
| Sex Factors | 2 | 2015 | 1741 | 0.070 |
Why?
| Odds Ratio | 3 | 2016 | 968 | 0.070 |
Why?
| S100 Proteins | 2 | 2018 | 39 | 0.070 |
Why?
| Antiviral Agents | 2 | 2023 | 651 | 0.070 |
Why?
| Child, Preschool | 6 | 2020 | 9164 | 0.070 |
Why?
| Monocytes | 2 | 2021 | 504 | 0.070 |
Why?
| Protein Structure, Tertiary | 1 | 2009 | 804 | 0.070 |
Why?
| Obesity | 1 | 2019 | 2523 | 0.070 |
Why?
| Keratins | 2 | 2019 | 176 | 0.070 |
Why?
| Mucins | 2 | 2018 | 62 | 0.070 |
Why?
| Aged | 6 | 2019 | 19292 | 0.070 |
Why?
| Binding Sites | 1 | 2009 | 1182 | 0.070 |
Why?
| Kinetics | 1 | 2009 | 1568 | 0.060 |
Why?
| Phylogeny | 1 | 2009 | 806 | 0.060 |
Why?
| Demography | 2 | 2020 | 264 | 0.060 |
Why?
| Severity of Illness Index | 3 | 2019 | 2590 | 0.060 |
Why?
| Homeostasis | 2 | 2020 | 577 | 0.060 |
Why?
| Genetic Markers | 2 | 2018 | 336 | 0.060 |
Why?
| Socioeconomic Factors | 3 | 2016 | 1088 | 0.050 |
Why?
| Diabetes Mellitus, Type 1 | 1 | 2019 | 3258 | 0.050 |
Why?
| Axonemal Dyneins | 1 | 2022 | 8 | 0.050 |
Why?
| Th1 Cells | 1 | 2023 | 125 | 0.050 |
Why?
| Interleukin-17 | 1 | 2023 | 106 | 0.050 |
Why?
| Chemokines | 1 | 2023 | 214 | 0.050 |
Why?
| Nippostrongylus | 1 | 2021 | 3 | 0.050 |
Why?
| Alternaria | 1 | 2021 | 7 | 0.050 |
Why?
| Bronchoalveolar Lavage | 1 | 2021 | 89 | 0.050 |
Why?
| Respiratory System | 1 | 2022 | 141 | 0.050 |
Why?
| Afghanistan | 1 | 2021 | 108 | 0.050 |
Why?
| Adoptive Transfer | 1 | 2021 | 200 | 0.050 |
Why?
| Esophageal Mucosa | 1 | 2020 | 17 | 0.050 |
Why?
| Mutation | 1 | 2011 | 3371 | 0.050 |
Why?
| Cohort Studies | 3 | 2020 | 4960 | 0.050 |
Why?
| Chromosomes, Human, Pair 12 | 1 | 2020 | 28 | 0.040 |
Why?
| Chromatin Immunoprecipitation | 1 | 2020 | 132 | 0.040 |
Why?
| Fibrosis | 1 | 2022 | 458 | 0.040 |
Why?
| Interleukin-5 | 1 | 2020 | 31 | 0.040 |
Why?
| Whole Genome Sequencing | 1 | 2020 | 110 | 0.040 |
Why?
| Dominican Republic | 1 | 2019 | 18 | 0.040 |
Why?
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2021 | 310 | 0.040 |
Why?
| Oligonucleotide Array Sequence Analysis | 2 | 2013 | 754 | 0.040 |
Why?
| Chemokine CCL26 | 1 | 2019 | 7 | 0.040 |
Why?
| Water Loss, Insensible | 1 | 2019 | 2 | 0.040 |
Why?
| Bleomycin | 1 | 2020 | 232 | 0.040 |
Why?
| Eugenol | 1 | 2018 | 3 | 0.040 |
Why?
| Arginase | 1 | 2019 | 27 | 0.040 |
Why?
| Acetophenones | 1 | 2018 | 14 | 0.040 |
Why?
| Intermediate Filament Proteins | 1 | 2019 | 69 | 0.040 |
Why?
| Drug Therapy, Combination | 1 | 2021 | 962 | 0.040 |
Why?
| Lymph Nodes | 1 | 2021 | 423 | 0.040 |
Why?
| Myocytes, Smooth Muscle | 1 | 2020 | 239 | 0.040 |
Why?
| Neutrophil Activation | 1 | 2019 | 94 | 0.040 |
Why?
| Nitric Oxide Synthase Type II | 1 | 2019 | 160 | 0.040 |
Why?
| Lipopolysaccharide Receptors | 1 | 2019 | 85 | 0.040 |
Why?
| Immunomodulation | 1 | 2019 | 86 | 0.040 |
Why?
| Genes, T-Cell Receptor | 1 | 2018 | 6 | 0.040 |
Why?
| Area Under Curve | 1 | 2019 | 277 | 0.040 |
Why?
| Infant | 3 | 2020 | 7992 | 0.040 |
Why?
| Genes, Immunoglobulin | 1 | 2018 | 26 | 0.040 |
Why?
| Receptors, Immunologic | 1 | 2019 | 203 | 0.040 |
Why?
| Smell | 1 | 2018 | 113 | 0.040 |
Why?
| Gene Ontology | 1 | 2017 | 47 | 0.040 |
Why?
| Disease Progression | 2 | 2016 | 2423 | 0.040 |
Why?
| Linear Models | 2 | 2010 | 777 | 0.040 |
Why?
| Epistasis, Genetic | 1 | 2017 | 69 | 0.040 |
Why?
| Flow Cytometry | 1 | 2020 | 1060 | 0.040 |
Why?
| Mice, Inbred NOD | 1 | 2019 | 562 | 0.040 |
Why?
| Spirometry | 1 | 2017 | 256 | 0.040 |
Why?
| Chronic Disease | 1 | 2023 | 1598 | 0.040 |
Why?
| Membrane Glycoproteins | 1 | 2019 | 433 | 0.030 |
Why?
| Geography, Medical | 1 | 2016 | 10 | 0.030 |
Why?
| Adenosine Triphosphate | 1 | 2018 | 430 | 0.030 |
Why?
| Treatment Outcome | 3 | 2020 | 9163 | 0.030 |
Why?
| Macrophages | 1 | 2023 | 1282 | 0.030 |
Why?
| Basophils | 1 | 2016 | 64 | 0.030 |
Why?
| Public Health Surveillance | 1 | 2016 | 61 | 0.030 |
Why?
| Reproducibility of Results | 2 | 2015 | 2807 | 0.030 |
Why?
| CD56 Antigen | 1 | 2015 | 34 | 0.030 |
Why?
| Respiratory Syncytial Viruses | 1 | 2015 | 47 | 0.030 |
Why?
| Base Sequence | 1 | 2019 | 2121 | 0.030 |
Why?
| Mast Cells | 1 | 2016 | 118 | 0.030 |
Why?
| Databases, Nucleic Acid | 1 | 2015 | 33 | 0.030 |
Why?
| Morbidity | 1 | 2016 | 278 | 0.030 |
Why?
| Logistic Models | 1 | 2020 | 1863 | 0.030 |
Why?
| Nitric Oxide | 1 | 2020 | 833 | 0.030 |
Why?
| Exome | 1 | 2015 | 206 | 0.030 |
Why?
| Organ Specificity | 1 | 2015 | 274 | 0.030 |
Why?
| Biopsy | 1 | 2018 | 1056 | 0.030 |
Why?
| Tetraspanin 24 | 1 | 2013 | 5 | 0.030 |
Why?
| Integrin alpha6 | 1 | 2013 | 8 | 0.030 |
Why?
| Immunization | 1 | 2016 | 402 | 0.030 |
Why?
| Cluster Analysis | 1 | 2015 | 466 | 0.030 |
Why?
| Thromboplastin | 1 | 2013 | 71 | 0.030 |
Why?
| Pneumonia | 1 | 2019 | 576 | 0.030 |
Why?
| Th17 Cells | 1 | 2013 | 58 | 0.030 |
Why?
| Nuclear Pore | 1 | 2012 | 14 | 0.030 |
Why?
| Mice, Transgenic | 1 | 2018 | 1971 | 0.030 |
Why?
| Aldehyde Dehydrogenase | 1 | 2013 | 129 | 0.030 |
Why?
| Age Factors | 1 | 2020 | 2911 | 0.030 |
Why?
| Gene Silencing | 1 | 2013 | 176 | 0.030 |
Why?
| T-Lymphocytes, Helper-Inducer | 1 | 2013 | 129 | 0.030 |
Why?
| Regeneration | 1 | 2013 | 162 | 0.030 |
Why?
| Adenocarcinoma | 1 | 2018 | 797 | 0.030 |
Why?
| Prednisone | 1 | 2012 | 232 | 0.020 |
Why?
| Bacteria | 1 | 2018 | 730 | 0.020 |
Why?
| Cell Line, Tumor | 1 | 2018 | 2749 | 0.020 |
Why?
| Cell Lineage | 1 | 2013 | 310 | 0.020 |
Why?
| Microbiota | 1 | 2019 | 652 | 0.020 |
Why?
| RNA Interference | 1 | 2013 | 438 | 0.020 |
Why?
| Mitochondrial Proton-Translocating ATPases | 1 | 2011 | 17 | 0.020 |
Why?
| Enzyme Activation | 1 | 2013 | 792 | 0.020 |
Why?
| Algorithms | 1 | 2018 | 1494 | 0.020 |
Why?
| Risk | 1 | 2013 | 829 | 0.020 |
Why?
| Molecular Chaperones | 1 | 2011 | 157 | 0.020 |
Why?
| Survival Analysis | 1 | 2013 | 1218 | 0.020 |
Why?
| Receptors, Interleukin-6 | 1 | 2009 | 35 | 0.020 |
Why?
| Saliva | 1 | 2010 | 189 | 0.020 |
Why?
| Suburban Population | 1 | 2008 | 16 | 0.020 |
Why?
| Reference Values | 1 | 2010 | 745 | 0.020 |
Why?
| Michigan | 1 | 2008 | 96 | 0.020 |
Why?
| Cross-Sectional Studies | 1 | 2018 | 4447 | 0.020 |
Why?
| Risk Assessment | 1 | 2016 | 2992 | 0.020 |
Why?
| Emigration and Immigration | 1 | 2007 | 45 | 0.020 |
Why?
| Acculturation | 1 | 2007 | 52 | 0.020 |
Why?
| Immunoglobulin E | 1 | 2008 | 363 | 0.020 |
Why?
| Cell Proliferation | 1 | 2013 | 2196 | 0.020 |
Why?
| RNA, Messenger | 1 | 2013 | 2581 | 0.020 |
Why?
| Interleukin-6 | 1 | 2009 | 677 | 0.020 |
Why?
| Environment | 1 | 2007 | 340 | 0.020 |
Why?
| Prognosis | 1 | 2010 | 3344 | 0.010 |
Why?
| Aged, 80 and over | 1 | 2010 | 6434 | 0.010 |
Why?
| Infant, Newborn | 1 | 2008 | 5084 | 0.010 |
Why?
| Pregnancy | 1 | 2008 | 5555 | 0.010 |
Why?
| Retrospective Studies | 1 | 2013 | 12615 | 0.010 |
Why?
|
|
Seibold's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|